Oppenheimer analyst Steven Lichtman upgraded AngioDynamics to Outperform from Perform with a $12 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ANGO: AngioDynamics Unveils Financial Outlook and Growth Plans AngioDynamics reports Q3 adjusted EPS (16c), consensus (13c) Options Volatility and Implied Earnings Moves Today, April 04, 2024 AngioDynamics’ AlphaVac F18 system receives 510(k) clearance for PE ANGO Earnings this Week: How Will it Perform?